Agile Therapeutics, Inc. (AGRX): Price and Financial Metrics


Agile Therapeutics, Inc. (AGRX)

Today's Latest Price: $2.97 USD

0.11 (3.85%)

Updated Jan 20 6:55pm

Add AGRX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 239 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

AGRX Stock Price Chart Interactive Chart >

Price chart for AGRX

AGRX Price/Volume Stats

Current price $2.97 52-week high $4.77
Prev. close $2.86 52-week low $1.35
Day low $2.85 Volume 1,298,400
Day high $2.99 Avg. volume 897,967
50-day MA $2.88 Dividend yield N/A
200-day MA $2.82 Market Cap 259.68M

Agile Therapeutics, Inc. (AGRX) Company Bio


Agile Therapeutics, Inc. focuses on the development and commercialization of prescription contraceptive products for women. The company was founded in 1997 and is based in Princeton, New Jersey.


AGRX Latest News Stream


Event/Time News Detail
Loading, please wait...

AGRX Latest Social Stream


Loading social stream, please wait...

View Full AGRX Social Stream

Latest AGRX News From Around the Web

Below are the latest news stories about Agile Therapeutics Inc that investors may wish to consider to help them evaluate AGRX as an investment opportunity.

Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference

PRINCETON, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced Chairman and…

GlobeNewswire | January 4, 2021

Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

PRINCETON, N.J., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced the Company will present at the 39th Annual J.P. Morgan Healthcare Conference, which is being held virtually, on Thursday, January 14, 2021, at 9:10 a.m. ET. A live webcast of the presentation will be available in the Events and Presentations section of the Agile Therapeutics Investor Relations page. The archived webcast will be available for 30 days.About Agile Therapeutics, Inc. Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women.  Our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-...

Yahoo | December 21, 2020

Hormonal Contraception Market Analysis by Size, Share, Growth, Trends up to 2026|Merck & Co., Inc., Pfizer, Inc., Agile Therapeutics, Inc.

A complete study of the global Hormonal Contraception market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of

OpenPR | December 16, 2020

Is AGRX A Good Stock To Buy Now?

Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that’s why their assets under management continue to swell). We believe hedge fund sentiment should serve as a crucial tool of an […]

Yahoo | December 12, 2020

Agile Therapeutics Announces Nationwide Commercial Launch and Availability of Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System, a New Non-Daily, Non-Invasive Contraceptive Patch - Stocks News Feed

Once-Weekly Twirla is the first and only contraceptive patch that combines levonorgestrel and ethinyl estradiol (EE) PRINCETON, N.J., Dec. 07, 2020 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the U.S. commercial launch of Twirla® (levonorgestrel and ethinyl estradiol) transdermal system, a new non-daily, non-invasive contraceptive patch. Twirla is… Read More »Agile Therapeutics Announces Nationwide Commercial Launch and Availability of Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System, a New Non-Daily, Non-Invasive Contraceptive Patch

Stocks News Feed | December 7, 2020

Read More 'AGRX' Stories Here

AGRX Price Returns

1-mo 0.00%
3-mo -0.67%
6-mo 21.22%
1-year 4.95%
3-year -15.14%
5-year -55.47%
YTD 3.48%
2020 14.80%
2019 331.03%
2018 -78.44%
2017 -52.81%
2016 -41.60%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8649 seconds.